QJSClass 2
Interoperable Automated Glycemic Controller, Insulin Suspend
FDA adverse event reports and recall history for interoperable automated glycemic controller, insulin suspend (product code QJS), from the public MAUDE corpus and the live FDA recall database.
- Total reports
- 325
- Deaths
- 0
- Injuries
- 172
- Malfunctions
- 153
Reports per year
221
122
32226
Source: FDA adverse event reports by year received, 2021–2026. Reporting paused twice in 2026 during FDA reporting-system changes and has since resumed.
Recent recalls
No recalls listed in the FDA device recall database for this entry.
Monitor interoperable automated glycemic controller, insulin suspend automatically
DeviceWatch watches FDA adverse events and recalls for the products you care about, summarizes clinical narratives with AI and alerts you when a safety signal emerges.